Skip to content
  • About
  • Events
  • Advocacy
  • Coalitions
  • About
  • Events
  • Advocacy
  • Coalitions
Facebook-square Icon-twitter-x Youtube
  • About
  • Events
  • Advocacy
  • Coalitions
  • About
  • Events
  • Advocacy
  • Coalitions

Category: Blog

Disneyland Measles Outbreak Stirs Vaccine Debate

Famously dubbed “the happiest place on earth,” Anaheim’s Disneyland has spawned a most unhappy event: an outbreak of measles, now affecting roughly 100 people.

“Cake” Brings Pain Issues to the Forefront

“Cake,” released in theaters nationwide Friday, has generated more than acting kudos for Jennifer Aniston.

Prior Authorizations, Care Rationing Block Hepatitis Patients’ Access to Cure

Will a cure for hepatitis remain a pipe dream for patients – despite new medical therapies?

AfPA Releases “Protecting Cancer Care” Video

Even the gravity of a life-threatening illness may not ensure cancer patients’ access to vital medications, AfPA’s recently released policy video explains.

Will Europe’s Regulatory Reorg Slow – or Speed – New Therapies to Patients?

The European Medicines Agency’s 18-month organizational overhaul is nearly complete.

Physicians Urge RSV Protection for Black Infants

“The Lives of Black Infants Matter!” the National Medical Association declared in a recent email update to members and colleagues.

As Biosimilar FDA Approval Nears, What Can Be Learned from India?

Last week, the United States inched closer to its first biosimilar approval. At a Wednesday meeting of the Food and Drug Administration’s Oncological Drugs Advisory Committee, panelists recommended approval for a filgrastim biosimilar.

New AfPA Video Calculates “The Cost of Specialty Tiers”

Americans who begin 2015 with a new health care plan may soon discover the hidden costs of an insurance payment structure known as specialty tiers.

New AfPA Video Urges Distinct Names, Comprehensive Testing for Biosimilars

The Alliance for Patient Access released today a new policy video offering a vital prescription for safe use of biosimilars: distinct naming conventions and comprehensive testing.

2014 in Review: The 7 Trends That Shaped Patient Access

Patient access encountered a range of challenges in 2014 – some old, some new. Here’s a look back at the top seven issues that drove physicians to advocate for their patients this year.

← Previous
Next →
  • STATE CHAPTERS
  • GLOBAL AFPA
  • INSTITUTE FOR PATIENT ACCESS
  • CONTACT US
  • STATE CHAPTERS
  • GLOBAL AFPA
  • INSTITUTE FOR PATIENT ACCESS
  • CONTACT US
Subscribe to our newsletter

© 2024, Alliance for Patient Access.

Website Management provided by Genacom
2020 K Street NW, Suite 505 Washington, DC 20006
[email protected]
(202) 951-7097
Facebook-square Icon-twitter-x Youtube